Looking to sell Imperative Care stock or options?
Imperative Care is a commercial-stage medical technology company dedicated to researching, developing, and manufacturing connected innovations to enhance care for individuals with vascular diseases. The company aims to address specific gaps in treatment and care, impacting the entire patient journey from detection to recovery for those with ischemic and hemorrhagic stroke. By transforming thrombectomy care for patients with severe vascular conditions, such as pulmonary embolism, Imperative Care enables healthcare providers to advance quality practices and elevate the standard of care.
Bain Capital Life Sciences, D1 Capital Partners, Incept, 3H Health Investment, Rock Springs Capital, Innovatus Capital Partners, Ally Bridge Group, Delos Capital Partners, HealthCor Management, Intai Technology, Catalio Capital Management, Ascension Ventures, Montreux Growth Partners, Pura Vida Investments, AMED Ventures, FemHealth Ventures.